Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer E Liu

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Journal of the American Heart Association|April 16, 2025
Independent and Incremental Value of ECG Markers for Prediction of Cancer Therapy-Related Cardiac DysfunctionIshmam Ibtida, Xiaoyue Ma, Mohammed Al-Sadawi, et al.
Circulation|August 6, 2025
Speckle-Tracking Strain Echocardiography for the Assessment of Left Ventricular Structure and Function: A Scientific Statement From the American Heart AssociationChristos G Mihos, Jennifer E Liu, Kelley M Anderson, et al.
Breast Cancer Research and Treatment|July 16, 2017
Cardiac safety of non-anthracycline trastuzumab-based therapy for HER2-positive breast cancerAnthony F Yu, Roy B Mukku, Shivani Verma, et al.
The American Journal of Cardiology|May 5, 2007
Relation between mitral annular calcium and complex aortic atheroma in patients with cerebral ischemia referred for transesophageal echocardiographyMaria G Karas, Steven Francescone, Alan Z Segal, et al.
JACC. Cardiooncology|October 26, 2020
Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted TherapyAnthony F Yu, Chaya S Moskowitz, Katherine Lee Chuy, et al.
American Heart Journal|January 31, 2006
Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS)Jorge R Kizer, Jonathan N Bella, Vittorio Palmieri, et al.
Annals of Epidemiology|April 10, 2003
An appraisal of echocardiography as an epidemiological tool. The Strong Heart StudyRichard B Devereux, Mary J Roman, Jennifer E Liu, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|July 14, 2007
Prognostic implications of relations of left ventricular systolic dysfunction with body composition and myocardial energy expenditure: the Strong Heart StudyVittorio Palmieri, Mary J Roman, Jonathan N Bella, et al.
European Heart Journal. Imaging Methods and Practice|June 30, 2025
Long-term cardiovascular consequences of cancer therapy-related cardiac dysfunction: insights from ventricular-arterial coupling and myocardial workAnthony F Yu, Jessica M Scott, Jessica Flynn, et al.
Cardio-Oncology (London, England)|March 9, 2023
Rationale and design of a cardiac safety study for reduced cardiotoxicity surveillance during HER2-targeted therapyAnthony F Yu, Chau T Dang, Justine Jorgensen, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Journal of the American Heart Association|April 16, 2025
Independent and Incremental Value of ECG Markers for Prediction of Cancer Therapy-Related Cardiac DysfunctionIshmam Ibtida, Xiaoyue Ma, Mohammed Al-Sadawi, et al.
Circulation|August 6, 2025
Speckle-Tracking Strain Echocardiography for the Assessment of Left Ventricular Structure and Function: A Scientific Statement From the American Heart AssociationChristos G Mihos, Jennifer E Liu, Kelley M Anderson, et al.
Breast Cancer Research and Treatment|July 16, 2017
Cardiac safety of non-anthracycline trastuzumab-based therapy for HER2-positive breast cancerAnthony F Yu, Roy B Mukku, Shivani Verma, et al.
The American Journal of Cardiology|May 5, 2007
Relation between mitral annular calcium and complex aortic atheroma in patients with cerebral ischemia referred for transesophageal echocardiographyMaria G Karas, Steven Francescone, Alan Z Segal, et al.
JACC. Cardiooncology|October 26, 2020
Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted TherapyAnthony F Yu, Chaya S Moskowitz, Katherine Lee Chuy, et al.
American Heart Journal|January 31, 2006
Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS)Jorge R Kizer, Jonathan N Bella, Vittorio Palmieri, et al.
Annals of Epidemiology|April 10, 2003
An appraisal of echocardiography as an epidemiological tool. The Strong Heart StudyRichard B Devereux, Mary J Roman, Jennifer E Liu, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|July 14, 2007
Prognostic implications of relations of left ventricular systolic dysfunction with body composition and myocardial energy expenditure: the Strong Heart StudyVittorio Palmieri, Mary J Roman, Jonathan N Bella, et al.
European Heart Journal. Imaging Methods and Practice|June 30, 2025
Long-term cardiovascular consequences of cancer therapy-related cardiac dysfunction: insights from ventricular-arterial coupling and myocardial workAnthony F Yu, Jessica M Scott, Jessica Flynn, et al.
Cardio-Oncology (London, England)|March 9, 2023
Rationale and design of a cardiac safety study for reduced cardiotoxicity surveillance during HER2-targeted therapyAnthony F Yu, Chau T Dang, Justine Jorgensen, et al.
Pageof 7